news

한어Русский языкEnglishFrançaisIndonesianSanskrit日本語DeutschPortuguêsΕλληνικάespañolItalianoSuomalainenLatina

Beijing News (Reporter Zhang Zhaohui) On August 9, Baiyang Pharmaceutical issued an announcement that it plans to jointly invest with Baiyang Zhongxin, Linkong Private Equity Fund, Linkong Industry Mother Fund, and Guidance Fund to establish Langfang Linkong Baiyang Equity Investment Fund Partnership (Limited Partnership) (tentative name, hereinafter referred to as the "Investment Fund").

Baiyang Zhongxin is the fund manager and executive partner of the partnership, Baiyang Zhongxin and Linkong Private Equity Fund are general partners of the partnership, and other investors are limited partners of the partnership. The subscribed capital of the investment fund is RMB 200 million, and Baiyang Pharmaceutical intends to subscribe RMB 59 million with its own funds as a limited partner, accounting for 29.50% of the total capital.

The registered address of the newly established investment fund is 2#202, No. 22, Airport Road, Langfang Section, Beijing Daxing International Airport Airside Economic Zone, Daxing Airport Area, China (Hebei) Pilot Free Trade Zone. Its business scope includes equity investment, investment management, asset management and other activities through private equity funds (it may only engage in business activities after completing filing and registration with the Asset Management Association of China).

Baiyang Pharmaceutical said that the establishment of an investment fund through this cooperation is in line with the company's development strategy and investment direction. The company can use the investment fund to deploy areas that are relevant and synergistic with the company's main business and improve the company's overall strategic layout.

Proofread by Zhao Lin